Brazil reached a deal with the UK to produce the COVID-19 vaccine that has been developed by Oxford University and AstraZeneca, Bloomberg reported.
Health Ministry Executive Secretary Elcio Franco said that Brazil will spend $287 million to buy vaccine doses and ingredients for as many as 100 million injections that it will be able to produce locally with the technology transfer.
The first order will cost Brazil $127 million, regardless of the final results of the vaccine clinical trials, Franco said.
"The research risk we’re taking is necessary given the urgency of an effective solution to maintain public health and resume economic growth," he added.
To read more NewsPoints articles, click here.